Tumor cell resistance to DNA topoisomerase II inhibitors: new developments

Author： Beck W.T.   Morgan S.E.   Mo Y-Y.   Bhat U.G.  

Publisher： Academic Press

ISSN： 1368-7646

Source： Drug Resistance Updates, Vol.2, Iss.6, 1999-12, pp. : 382-389

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DNA topoisomerase II inhibitors: new approaches to antitumour therapy

By  

Inpharma, Vol. 1, Iss. 1341, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Recent Developments of DNA Poisons - Human DNA Topoisomerase II Inhibitors - as Anticancer Agents

By  

Current Pharmaceutical Design, Vol. 19, Iss. 13, 2013-04 ,pp. : 2474-2488

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer Resistance to Type II Topoisomerase Inhibitors

By  

Current Medicinal Chemistry, Vol. 19, Iss. 23, 2012-08 ,pp. : 3900-3906

Bentham Science Publishers

Access to resources Recommend Favorite

DNA Repair and Resistance to Topoisomerase I Inhibitors: Mechanisms, Biomarkers and Therapeutic Targets

By  

Current Medicinal Chemistry, Vol. 19, Iss. 23, 2012-08 ,pp. : 3874-3885

Bentham Science Publishers

Access to resources Recommend Favorite

Toxicity of the topoisomerase II inhibitors

By Seiter Karen  

Expert Opinion on Drug Safety, Vol. 4, Iss. 2, 2005-03 ,pp. : 219-234

Informa Healthcare

Access to resources Recommend Favorite